- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Picker settlement rejected in ISO suit
Picker International believedit had reached a settlement agreement last month with a formerservice employee, Bruce Leavitt. Leavitt is a co-defendant inthe vendor's seven-year legal battle with independent serviceorganization Imaging Equipment Services
Picker International believedit had reached a settlement agreement last month with a formerservice employee, Bruce Leavitt. Leavitt is a co-defendant inthe vendor's seven-year legal battle with independent serviceorganization Imaging Equipment Services of Pittsburgh and itspresident, Tom Quinn. However, the settlement agreement was rejectedby the judge in the case, who asked the parties to continue talking.
In June, the judge granted Picker's motion for summary judgment,which effectively dismissed IES' antitrust suit against Picker(SCAN 6/15/94). The judge issued a memorandum outlining his reasoningfor the ruling last month. IES intends to appeal the judgmentbut will wait until Picker's case against the ISO is tried, Quinnsaid. That case is scheduled for court this month.
Meanwhile, Quinn obtained documents from the inspector general'soffice of the Department of Defense that indicate another governmentinvestigation of medical imaging OEM practices may be under way.The Department of Justice requested in July that IES turn overall documents in its lawsuit with Picker as part of its antitrustinvestigation of the medical imaging industry (SCAN 7/27/94).
Last month, DOD refused to supply Quinn with Picker-relateddocuments under a freedom-of-information request due to "anongoing criminal investigation," the DOD said.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
